Participating Countries
Currently there are 37 members of the European Pharmacopoeia Commission: Austria, Belgium, Bosnia and Herzegovina, Bulgaria, Croatia, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Lithuania, Luxembourg, Malta, Montenegro, Netherlands, Norway, Poland, Portugal, Romania, Serbia, Slovak Republic, Slovenia, Spain, Sweden, Switzerland, Republic of Macedonia, Turkey, United Kingdom, and the European Union.
In these countries and the European Union the Ph. Eur. is the official pharmacopoeia. Additional local pharmacopoeias may exist (e. g. in United Kingdom and Germany). Not all of these countries are member states of the European Union.
Observers from 20 member and non-member states of the Council of Europe and international organisations take part on sessions of the European Pharmacopoeial Commission: Albania, Algeria, Australia, Belarus, Brazil, Canada, China, Georgia, Israel, Madagascar, Malaysia, Morocco, Kazakhstan, Russian Federation, Senegal, Syria, Tunisia, Ukraine, United States of America, and the WHO.
The convention is open for signature by all European countries. Other countries can get observer status.
Read more about this topic: European Pharmacopoeia
Famous quotes containing the word countries:
“In some things, we Americans leave to other countries the carrying out of the principle that stands at the head of our Declaration of Independence.”
—Herman Melville (1819–1891)